An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens

[1]  C. Janse,et al.  An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens , 2017, Scientific Reports.

[2]  A. Hill,et al.  Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine , 2017, Scientific Reports.

[3]  M. Bachmann,et al.  Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine , 2017, Clinical and Vaccine Immunology.

[4]  A. Hill,et al.  Viral vectors as vaccine platforms: from immunogenicity to impact. , 2016, Current opinion in immunology.

[5]  R. Sinden,et al.  Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP , 2016, Journal of Infectious Diseases.

[6]  A. Blagborough,et al.  Tailoring a Combination Preerythrocytic Malaria Vaccine , 2015, Infection and Immunity.

[7]  Yuming Guo,et al.  The effect of air pollution on human physiological function in China: a longitudinal study , 2015, The Lancet.

[8]  U. Dalrymple,et al.  The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015 , 2015, Nature.

[9]  C. Janse,et al.  Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates , 2015, Scientific Reports.

[10]  A. Nicosia,et al.  Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults , 2015, Science Translational Medicine.

[11]  Peter G. Kremsner,et al.  Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. , 2015 .

[12]  R. Longley,et al.  Development of an In Vitro Assay and Demonstration of Plasmodium berghei Liver-Stage Inhibition by TRAP-Specific CD8+ T Cells , 2015, PloS one.

[13]  R. Cortese,et al.  Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals , 2014, The Journal of infectious diseases.

[14]  C. Janse,et al.  Generation of Transgenic Rodent Malaria Parasites Expressing Human Malaria Parasite Proteins. , 2015, Methods in molecular biology.

[15]  M. Pepper,et al.  Antibody and B cell responses to Plasmodium sporozoites , 2014, Front. Microbiol..

[16]  A. Folgori,et al.  Enhanced Vaccine-Induced CD8+ T Cell Responses to Malaria Antigen ME-TRAP by Fusion to MHC Class II Invariant Chain , 2014, PloS one.

[17]  G. van Gemert,et al.  Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum , 2014, Malaria Journal.

[18]  K. Matuschewski,et al.  Post‐transcriptional silencing of UIS4 in Plasmodium berghei sporozoites is important for host switch , 2014, Molecular microbiology.

[19]  A. Vaughan,et al.  Model for In Vivo Assessment of Humoral Protection against Malaria Sporozoite Challenge by Passive Transfer of Monoclonal Antibodies and Immune Serum , 2013, Infection and Immunity.

[20]  A. Folgori,et al.  Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation , 2013, Nature Communications.

[21]  K. Matuschewski,et al.  Identification of Targets of CD8+ T Cell Responses to Malaria Liver Stages by Genome-wide Epitope Profiling , 2013, PLoS pathogens.

[22]  A. Ghani,et al.  The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection , 2013, PloS one.

[23]  M. Mota,et al.  Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry. , 2013, Methods in molecular biology.

[24]  S. Gilbert,et al.  Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors , 2012, Biotechnology and bioengineering.

[25]  A. Folgori,et al.  Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector , 2012, The Journal of infectious diseases.

[26]  M. Mota,et al.  A toolbox to study liver stage malaria. , 2011, Trends in parasitology.

[27]  C. Whitty.  The RTS,S malaria vaccine , 2011, BMJ : British Medical Journal.

[28]  P. de la Vega,et al.  Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei , 2010, PloS one.

[29]  G. van Gemert,et al.  Temperature Shift and Host Cell Contact Up-Regulate Sporozoite Expression of Plasmodium falciparum Genes Involved in Hepatocyte Infection , 2008, PLoS pathogens.

[30]  M. Prevost,et al.  Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. , 2008, Cell host & microbe.

[31]  P. Baldacci,et al.  Serial Analysis of Gene Expression in Plasmodium berghei salivary gland sporozoites , 2007, BMC Genomics.

[32]  C. Janse,et al.  Selection by flow-sorting of genetically transformed, GFP-expressing blood stages of the rodent malaria parasite, Plasmodium berghei , 2006, Nature Protocols.

[33]  K. Matuschewski,et al.  High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. , 2006, Molecular and biochemical parasitology.

[34]  P. Sinnis,et al.  The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion , 2005, The Journal of experimental medicine.

[35]  V. Nussenzweig,et al.  Quantitative Plasmodium sporozoite neutralization assay (TSNA). , 2004, Journal of immunological methods.

[36]  S. Kappe,et al.  Transformation of Sporozoites into Early Exoerythrocytic Malaria Parasites Does Not Require Host Cells , 2003, The Journal of experimental medicine.

[37]  S. Hoffman,et al.  Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. , 1991, Science.

[38]  L. Rénia,et al.  Malaria sporozoite penetration. A new approach by double staining. , 1988, Journal of immunological methods.

[39]  D. Mazier,et al.  Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. , 1986, Science.

[40]  V. Nussenzweig,et al.  Immunoradiometric assay to measure the in vitro penetration of sporozoites of malaria parasites into hepatoma cells. , 1985, Journal of immunology.

[41]  E. Nardin,et al.  Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. , 1984, Journal of immunology.

[42]  M. Hollingdale,et al.  Inhibition of Plasmodium berghei sporozoite invasion of cultured hepatoma cells. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[43]  V. Nussenzweig,et al.  Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax , 1982, The Journal of experimental medicine.

[44]  V. Nussenzweig,et al.  Antibodies to the protective antigen of Plasmodium berghei sporozoites prevent entry into cultured cells. , 1982, Journal of immunology.

[45]  J. Vanderberg,et al.  Some physiological and metabolic problems related to maintenance of the Plasmodium berghei cycle in Anopheles quadrimaculatus. , 1965, Annales des Societes belges de medecine tropicale, de parasitologie, et de mycologie.